BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
26 hedge funds and large institutions have $9.18M invested in Baudax Bio, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
85% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 13
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
26
Holding in Top 10
–
Calls
$272K
Puts
$467K
Top Buyers
| 1 | +$100K | |
| 2 | +$98K | |
| 3 | +$85.5K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$77.7K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$29K |
Top Sellers
| 1 | -$1.21M | |
| 2 | -$395K | |
| 3 | -$202K | |
| 4 |
Jane Street
New York
|
-$164K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$112K |